Profound Inhibition of Myogenic Tone in Rat Cardiac Allografts Is Due to eNOS- and iNOS-Based Nitric Oxide and an Intrinsic Defect in Vascular Smooth Muscle Contraction
- 21 March 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (11) , 1303-1310
- https://doi.org/10.1161/01.cir.101.11.1303
Abstract
Background—The physiological consequences of inducible NO synthase (iNOS) expression were studied in allograft coronary arteries by pressure myography. Methods and Results—Septal coronary arteries ...Keywords
This publication has 11 references indexed in Scilit:
- Nitric oxide and its role in the cardiovascular systemProgress in Cardiovascular Diseases, 1995
- Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejectionInternational Journal of Cardiology, 1995
- Induction of myocardial nitric oxide synthase by cardiac allograft rejection.Journal of Clinical Investigation, 1994
- Effects of NG-Methyl-L-arginine, NG-Nitro-L-arginine, and Aminoguanidine on Constitutive and Inducible Nitric Oxide Synthase in Rat AortaBiochemical and Biophysical Research Communications, 1994
- Aminoguanidine selectively inhibits inducible nitric oxide synthaseBritish Journal of Pharmacology, 1993
- Selective inhibition of the inducible nitric oxide synthase by aminoguanidineEuropean Journal of Pharmacology, 1993
- Persistence of coronary vasodilator responsivity after cardiac transplantationThe American Journal of Cardiology, 1993
- Cellular mechanisms involved in the vascular myogenic responseAmerican Journal of Physiology-Heart and Circulatory Physiology, 1992
- Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular DysfunctionDiabetes, 1992
- Reassessment of fura-2 and the ratio method for determination of intracellular Ca2+ concentrationsCell Calcium, 1991